,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,1.79845011118776e-07,0.000147832599139634
2,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,2.66273941875876e-05,0.00831203178507182
3,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Up,3.03358824272694e-05,0.00831203178507182
4,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.000109497349359202,0.022501705293316
5,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.000183950824769715,0.0286777429982069
6,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.000209326591227788,0.0286777429982069
7,WP_ZINC_HOMEOSTASIS,23,Down,0.000645311066382518,0.0757779566523471
8,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.000750443803954757,0.0771081008563513
9,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.0010254384632873,0.0936567129802404
10,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.00117908372528791,0.0969206822186666
11,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.00230455822866791,0.172156306224899
12,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.00251323074780874,0.172156306224899
13,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.00284395450175413,0.174946550504478
14,WP_ALPHA_6_BETA_4_SIGNALING,25,Up,0.00297962494776484,0.174946550504478
15,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Up,0.00389151558007055,0.213255053787866
16,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.00467155751718499,0.240001267445379
17,WP_IL5_SIGNALING,37,Up,0.00522767814552834,0.252773613860253
18,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Up,0.0056944157358968,0.260044985272621
19,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.00689335805828576,0.297677183560457
20,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.00724275385791867,0.297677183560457
21,WP_DRAVET_SYNDROME,12,Up,0.0080127584675774,0.313642260016601
22,WP_LUNG_PATHOLOGY_OF_COVID19,14,Up,0.00865002803362528,0.323196501983636
23,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Up,0.0101414491858308,0.362446575250127
24,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,12,Down,0.0113588865126668,0.389041863058839
25,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.0122658406486796,0.403300840528585
26,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.0134066835999187,0.41461760365614
27,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.0136188263974644,0.41461760365614
28,WP_IL3_SIGNALING,46,Up,0.0158590975889059,0.449888834178782
29,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.0159619704036675,0.449888834178782
30,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Down,0.0164193005174738,0.449888834178782
31,WP_BENZOAPYRENE_METABOLISM,5,Down,0.0172876003174841,0.450237334475099
32,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.0175274874734832,0.450237334475099
33,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.0181960902758485,0.453248066871135
34,WP_PROSTAGLANDIN_SIGNALING,21,Up,0.0194778433978421,0.460344313149627
35,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.0196010352314318,0.460344313149627
36,WP_OSTEOBLAST_SIGNALING,2,Up,0.0204467044478855,0.464142578576497
37,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,24,Down,0.021682663741357,0.464142578576497
38,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.0220235366805724,0.464142578576497
39,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,56,Up,0.0227846618679605,0.464142578576497
40,WP_THERMOGENESIS,74,Up,0.0229210315040238,0.464142578576497
41,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,14,Down,0.0234214420785946,0.464142578576497
42,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Up,0.0240813093074046,0.464142578576497
43,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.0244884874869434,0.464142578576497
44,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.0252756846556376,0.464142578576497
45,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Up,0.0254092652505382,0.464142578576497
46,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.0261203911845676,0.466760033776403
47,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.0270581218434918,0.473229279901069
48,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Up,0.0285500539664387,0.488919674175263
49,WP_MONOAMINE_GPCRS,3,Up,0.0318421171747914,0.5313503213116
50,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.0323205791552068,0.5313503213116
51,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.0342456527668957,0.551700594547873
52,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.0349007675383083,0.551700594547873
53,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.0365838447738538,0.563760536436398
54,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.0375125474874108,0.563760536436398
55,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,21,Up,0.0385164636832556,0.563760536436398
56,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,22,Up,0.0386112885141128,0.563760536436398
57,WP_IDO_METABOLIC_PATHWAY,6,Up,0.0390928839134729,0.563760536436398
58,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,6,Up,0.0406517340325919,0.576133196117078
59,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,35,Up,0.0432897925078103,0.587785727161303
60,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,62,Up,0.0438901657327325,0.587785727161303
61,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,8,Up,0.0459797529966227,0.587785727161303
62,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.0465544951589406,0.587785727161303
63,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.0466631117913616,0.587785727161303
64,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.0489079744114694,0.587785727161303
65,WP_MITOCHONDRIAL_GENE_EXPRESSION,17,Down,0.0493173574144892,0.587785727161303
66,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,10,Up,0.0499363941795916,0.587785727161303
67,WP_PROTEASOME_DEGRADATION,57,Down,0.0511938629958808,0.587785727161303
68,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Up,0.0514053348116732,0.587785727161303
69,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.0514217942129109,0.587785727161303
70,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,6,Up,0.0518062982280786,0.587785727161303
71,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.0520240262438916,0.587785727161303
72,WP_PURINERGIC_SIGNALING,15,Up,0.0520656166873957,0.587785727161303
73,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,53,Up,0.0527167720025067,0.587785727161303
74,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.0529150168004093,0.587785727161303
75,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.0546552916569881,0.59902199656059
76,WP_ECTODERM_DIFFERENTIATION,75,Up,0.0569729179690633,0.616207086454869
77,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.0597993671947234,0.624394740100987
78,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.0605362007795757,0.624394740100987
79,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.060768910794305,0.624394740100987
80,WP_PPAR_SIGNALING,38,Down,0.0610633112742969,0.624394740100987
81,WP_SPINA_BIFIDA,10,Down,0.061527948842068,0.624394740100987
82,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Up,0.0642780614015915,0.644348371611076
83,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Up,0.0655145795640144,0.648831137368914
84,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Up,0.0672751205490458,0.654475765188414
85,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.0677750307635725,0.654475765188414
86,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.0684731335841893,0.654475765188414
87,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.0700173496258238,0.661543234395714
88,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.0712270140432737,0.665325062995125
89,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.0733087700645059,0.671613168047563
90,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Up,0.0737512000642612,0.671613168047563
91,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.0755921785235439,0.671613168047563
92,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.0765614695148795,0.671613168047563
93,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.0767043370517283,0.671613168047563
94,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.0768024790711325,0.671613168047563
95,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.0779285864652657,0.673978092073065
96,WP_IL6_SIGNALING,39,Up,0.0798964915053525,0.673978092073065
97,WP_COMPLEMENT_SYSTEM,50,Down,0.0809651313032887,0.673978092073065
98,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.0820706367785061,0.673978092073065
99,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.0821179554008363,0.673978092073065
100,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.0825053534122755,0.673978092073065
101,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.0828123933082477,0.673978092073065
102,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,6,Up,0.0858492056138099,0.69184359818188
103,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.0906579934090739,0.716890159824209
104,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,33,Up,0.091537064617936,0.716890159824209
105,WP_EICOSANOID_SYNTHESIS,14,Down,0.0917608140925386,0.716890159824209
106,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.0924456897096911,0.716890159824209
107,WP_ENDOMETRIAL_CANCER,49,Up,0.0954126282869549,0.72940591614091
108,WP_IL11_SIGNALING,41,Up,0.0971387477079913,0.72940591614091
109,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.0989255125619684,0.72940591614091
110,WP_PROLACTIN_SIGNALING,69,Up,0.0994613257854873,0.72940591614091
111,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.100466955494916,0.72940591614091
112,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.100477685655097,0.72940591614091
113,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.102689483288699,0.72940591614091
114,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.102808666383436,0.72940591614091
115,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Up,0.107279953504488,0.72940591614091
116,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.107463048307898,0.72940591614091
117,WP_BREAST_CANCER_PATHWAY,88,Up,0.107501072924598,0.72940591614091
118,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.109341388111025,0.72940591614091
119,WP_CHEMOKINE_SIGNALING,108,Up,0.110200538572561,0.72940591614091
120,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.111179370169661,0.72940591614091
121,WP_STEROID_BIOSYNTHESIS,2,Down,0.111690587493114,0.72940591614091
122,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.112432175746676,0.72940591614091
123,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Up,0.112745034387368,0.72940591614091
124,WP_ONECARBON_METABOLISM,23,Down,0.112911016953449,0.72940591614091
125,WP_OSTEOPONTIN_SIGNALING,11,Down,0.113117769278597,0.72940591614091
126,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.113856686124551,0.72940591614091
127,WP_NETRINUNC5B_SIGNALING,35,Up,0.113874957802764,0.72940591614091
128,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.114011448754023,0.72940591614091
129,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.117109732959313,0.72940591614091
130,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.117832607461032,0.72940591614091
131,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.119737333884198,0.72940591614091
132,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Up,0.119842531936418,0.72940591614091
133,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Up,0.120237594669895,0.72940591614091
134,WP_KIT_RECEPTOR_SIGNALING,52,Up,0.122424360167313,0.72940591614091
135,WP_OVARIAN_INFERTILITY,23,Up,0.122676853758647,0.72940591614091
136,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.122766885268643,0.72940591614091
137,WP_HUNGER_AND_SATIETY,2,Up,0.122950511383568,0.72940591614091
138,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,67,Down,0.123059556715002,0.72940591614091
139,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Up,0.125006571001117,0.72940591614091
140,WP_B_CELL_RECEPTOR_SIGNALING,86,Up,0.125175751977791,0.72940591614091
141,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,53,Up,0.125614364814734,0.72940591614091
142,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.126004428335778,0.72940591614091
143,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.127882637132188,0.732739135076798
144,WP_RETINOL_METABOLISM,6,Up,0.128363060159439,0.732739135076798
145,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,28,Up,0.130096862450385,0.732853776422398
146,WP_RAC1PAK1P38MMP2_PATHWAY,53,Up,0.130166242527579,0.732853776422398
147,WP_KLEEFSTRA_SYNDROME,24,Up,0.131212067961383,0.733716461661609
148,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Up,0.139078461741127,0.749236790283748
149,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.13953196960725,0.749236790283748
150,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.139730631733875,0.749236790283748
151,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Up,0.139763091693238,0.749236790283748
152,WP_KININKALLIKREIN_PATHWAY,2,Down,0.141509110713189,0.749236790283748
153,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.141641518249503,0.749236790283748
154,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.142966040293541,0.749236790283748
155,WP_GALANIN_RECEPTOR_PATHWAY,10,Up,0.144093057528717,0.749236790283748
156,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.144263136556705,0.749236790283748
157,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Up,0.145037116489093,0.749236790283748
158,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.145370093939927,0.749236790283748
159,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Up,0.145749205798985,0.749236790283748
160,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Down,0.145836844824087,0.749236790283748
161,WP_IL2_SIGNALING,36,Up,0.149397351504761,0.762761633148534
162,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.150888251812077,0.765618166602022
163,WP_LUNG_FIBROSIS,29,Up,0.15308237843114,0.767429882491461
164,WP_TAMOXIFEN_METABOLISM,2,Up,0.153827232713929,0.767429882491461
165,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,10,Up,0.154046144295731,0.767429882491461
166,WP_VEGFAVEGFR2_SIGNALING,342,Up,0.156011607605428,0.770694392025675
167,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.157166197494912,0.770694392025675
168,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.157514182311817,0.770694392025675
169,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Up,0.158767598086628,0.772230565841468
170,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.160028207955773,0.773783452586151
171,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.162502638053071,0.776755549823749
172,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.162532791447305,0.776755549823749
173,WP_IL4_SIGNALING,50,Up,0.165897480739331,0.788070218942648
174,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.166817783571801,0.788070218942648
175,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.170002571976344,0.795871872908962
176,WP_FOCAL_ADHESION,116,Up,0.17040565648659,0.795871872908962
177,WP_FERROPTOSIS,50,Down,0.174009471648767,0.808111783589187
178,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.177461335848574,0.819512461053526
179,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.181008736319739,0.831224476283942
180,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.183290882278761,0.837028362406343
181,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.186557866697828,0.845565035692786
182,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.187217562647308,0.845565035692786
183,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Up,0.190336149385156,0.850022616223395
184,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,21,Up,0.191311381309197,0.850022616223395
185,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Up,0.191318885751768,0.850022616223395
186,WP_PPARALPHA_PATHWAY,15,Down,0.194122162525017,0.850022616223395
187,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.194635746490046,0.850022616223395
188,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.195024489910563,0.850022616223395
189,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.195443156284941,0.850022616223395
190,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.204631609160635,0.877908355971856
191,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.205363334688551,0.877908355971856
192,WP_TNFALPHA_SIGNALING,83,Up,0.208882910712595,0.877908355971856
193,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.210003437863739,0.877908355971856
194,WP_HEPATITIS_B_INFECTION,116,Up,0.210542892684046,0.877908355971856
195,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.210703670578153,0.877908355971856
196,WP_MELANOMA,56,Up,0.212145401517586,0.877908355971856
197,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.213916926489489,0.877908355971856
198,WP_CORI_CYCLE,11,Down,0.214143757317051,0.877908355971856
199,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Up,0.215068798991976,0.877908355971856
200,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.217151882369995,0.877908355971856
201,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,9,Up,0.21868732176412,0.877908355971856
202,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.225404303712174,0.877908355971856
203,WP_TRANSLATION_FACTORS,49,Up,0.226259136555319,0.877908355971856
204,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.227060408477116,0.877908355971856
205,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.22841108803902,0.877908355971856
206,WP_ARYLAMINE_METABOLISM,1,Up,0.232100960261478,0.877908355971856
207,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Up,0.232231193725267,0.877908355971856
208,WP_NONSMALL_CELL_LUNG_CANCER,60,Up,0.232682998689023,0.877908355971856
209,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,91,Up,0.23664685548824,0.877908355971856
210,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.239602735886148,0.877908355971856
211,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.239867282947861,0.877908355971856
212,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.240975186083953,0.877908355971856
213,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Up,0.241697557244221,0.877908355971856
214,WP_FRAGILE_X_SYNDROME,84,Up,0.244192601199339,0.877908355971856
215,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Up,0.244404692088892,0.877908355971856
216,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.244832867830726,0.877908355971856
217,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Down,0.245848977352349,0.877908355971856
218,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Up,0.246206771353644,0.877908355971856
219,WP_BURN_WOUND_HEALING,59,Up,0.246763121466961,0.877908355971856
220,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.246827502732286,0.877908355971856
221,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Up,0.247254493788207,0.877908355971856
222,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Up,0.248430295553597,0.877908355971856
223,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.250884246065906,0.877908355971856
224,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.253510106221024,0.877908355971856
225,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Up,0.254286781174881,0.877908355971856
226,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.254402537232052,0.877908355971856
227,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Up,0.25608485999673,0.877908355971856
228,WP_P38_MAPK_SIGNALING,31,Up,0.257446167599253,0.877908355971856
229,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.258001737555965,0.877908355971856
230,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Up,0.259047894921842,0.877908355971856
231,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Up,0.259424518017496,0.877908355971856
232,WP_HISTONE_MODIFICATIONS,37,Up,0.259549519456196,0.877908355971856
233,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.261066306834419,0.877908355971856
234,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.261233465117412,0.877908355971856
235,WP_PYRIMIDINE_METABOLISM,74,Down,0.263035359088775,0.877908355971856
236,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.263494238484034,0.877908355971856
237,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.263613213067691,0.877908355971856
238,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.26489240959334,0.877908355971856
239,WP_MATRIX_METALLOPROTEINASES,8,Up,0.26548411502872,0.877908355971856
240,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Up,0.26585047939806,0.877908355971856
241,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.267033558418181,0.877908355971856
242,WP_CHOLESTASIS,9,Up,0.268202474072179,0.877908355971856
243,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.268316980560262,0.877908355971856
244,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.268664867739821,0.877908355971856
245,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,10,Up,0.268668213688557,0.877908355971856
246,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.273050700551156,0.877908355971856
247,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Down,0.274127500223266,0.877908355971856
248,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.278375510210097,0.877908355971856
249,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.279720581475042,0.877908355971856
250,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.280823081197907,0.877908355971856
251,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.282344809307413,0.877908355971856
252,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.283240826563156,0.877908355971856
253,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.284027912973082,0.877908355971856
254,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,2,Up,0.284313863610516,0.877908355971856
255,WP_ONCOSTATIN_M_SIGNALING,54,Up,0.285543645926129,0.877908355971856
256,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Up,0.287381559996065,0.877908355971856
257,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.288707825405692,0.877908355971856
258,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Up,0.289278975904626,0.877908355971856
259,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,30,Up,0.290245303219242,0.877908355971856
260,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Down,0.290406049751312,0.877908355971856
261,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.291316617141119,0.877908355971856
262,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.29153091736444,0.877908355971856
263,WP_16P112_PROXIMAL_DELETION_SYNDROME,60,Up,0.291811485282661,0.877908355971856
264,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.292592861892897,0.877908355971856
265,WP_NEPHROTIC_SYNDROME,29,Up,0.29340299698589,0.877908355971856
266,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.293807420968248,0.877908355971856
267,WP_MTHFR_DEFICIENCY,18,Up,0.294719142556132,0.877908355971856
268,WP_APOPTOSIS,71,Up,0.297249831902053,0.877908355971856
269,WP_ERBB_SIGNALING,68,Up,0.297727537595251,0.877908355971856
270,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Up,0.298254936716693,0.877908355971856
271,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Up,0.298254936716693,0.877908355971856
272,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.298714898146298,0.877908355971856
273,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.298723296833192,0.877908355971856
274,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.298950205262045,0.877908355971856
275,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.299230613205293,0.877908355971856
276,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,84,Up,0.299453861568717,0.877908355971856
277,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.301552429336857,0.877908355971856
278,WP_NUCLEAR_RECEPTORS,20,Down,0.302278542228234,0.877908355971856
279,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.302325245061364,0.877908355971856
280,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Down,0.302482222975908,0.877908355971856
281,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.302550668316458,0.877908355971856
282,WP_OSTEOCLAST_SIGNALING,8,Down,0.302904499470327,0.877908355971856
283,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.303009101284442,0.877908355971856
284,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Down,0.307724570699048,0.877908355971856
285,WP_IL1_SIGNALING,53,Up,0.308347413002983,0.877908355971856
286,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,51,Up,0.308414256367422,0.877908355971856
287,WP_GASTRIC_CANCER_NETWORK_2,27,Up,0.30943689438547,0.877908355971856
288,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,8,Up,0.309825685171183,0.877908355971856
289,WP_10Q22Q23_COPY_NUMBER_VARIATION,28,Up,0.31025559544785,0.877908355971856
290,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.310334640242983,0.877908355971856
291,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.311185927190694,0.877908355971856
292,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.311860389226012,0.877908355971856
293,WP_PI3KAKT_SIGNALING,176,Up,0.315586024434409,0.881448944623273
294,WP_GASTRIN_SIGNALING,92,Up,0.316071947987922,0.881448944623273
295,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.317036560420665,0.881448944623273
296,WP_PDGF_PATHWAY,36,Up,0.317407405849743,0.881448944623273
297,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.319349619114263,0.882997567307168
298,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.320174563911163,0.882997567307168
299,WP_CILIOPATHIES,127,Up,0.321187679592267,0.882997567307168
300,WP_TGFB_SMAD_SIGNALING,7,Up,0.32414295394048,0.886046032973592
301,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.326521693999615,0.886046032973592
302,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Down,0.328365632089029,0.886046032973592
303,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Up,0.328446983435032,0.886046032973592
304,WP_REGULATION_OF_ACTIN_CYTOSKELETON,91,Up,0.328827403348214,0.886046032973592
305,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.329444611789116,0.886046032973592
306,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.329875941435306,0.886046032973592
307,WP_TP53_NETWORK,16,Up,0.332391322420128,0.886046032973592
308,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,60,Up,0.332504435073651,0.886046032973592
309,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.333075698526569,0.886046032973592
310,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.336393130071472,0.891501288891767
311,WP_WNT_SIGNALING_WP428,56,Up,0.339127366788959,0.891501288891767
312,WP_AEROBIC_GLYCOLYSIS,10,Down,0.340532008743431,0.891501288891767
313,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.340532008743431,0.891501288891767
314,WP_SMALL_LIGAND_GPCRS,7,Up,0.34054915415087,0.891501288891767
315,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.34566078755981,0.902010055156077
316,WP_MAPK_SIGNALING,159,Up,0.34813606573817,0.903973361513244
317,WP_RANKLRANK_SIGNALING,48,Up,0.349044463078935,0.903973361513244
318,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,52,Up,0.349733455786245,0.903973361513244
319,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.352553022839471,0.903973361513244
320,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.354219147696444,0.903973361513244
321,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,7,Up,0.356548180017266,0.903973361513244
322,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Up,0.356591039161425,0.903973361513244
323,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Up,0.360262223172458,0.903973361513244
324,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,28,Up,0.362485414499039,0.903973361513244
325,WP_NEUROINFLAMMATION,10,Up,0.364388702137615,0.903973361513244
326,WP_GLIOBLASTOMA_SIGNALING,69,Up,0.368262805876136,0.903973361513244
327,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.368715108317038,0.903973361513244
328,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.36887023730202,0.903973361513244
329,WP_JOUBERT_SYNDROME,70,Up,0.370314818884892,0.903973361513244
330,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Down,0.371356868163955,0.903973361513244
331,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Up,0.371383688442042,0.903973361513244
332,WP_CELLULAR_PROTEOSTASIS,6,Down,0.371483618815532,0.903973361513244
333,WP_NUCLEOTIDE_GPCRS,5,Up,0.3721478722254,0.903973361513244
334,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.372431492987988,0.903973361513244
335,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.372853119076219,0.903973361513244
336,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.373798136270611,0.903973361513244
337,WP_IRON_METABOLISM_DISORDERS,13,Up,0.373831010104722,0.903973361513244
338,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.374003727314578,0.903973361513244
339,WP_BLADDER_CANCER,29,Up,0.376326569041557,0.903973361513244
340,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Down,0.378404356630522,0.903973361513244
341,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.379772077646377,0.903973361513244
342,WP_CELL_DIFFERENTIATION_INDEX,6,Up,0.380449715265613,0.903973361513244
343,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.381432783996861,0.903973361513244
344,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.381786632349345,0.903973361513244
345,WP_NOTCH_SIGNALING_WP61,49,Up,0.38430736041825,0.903973361513244
346,WP_GPCRS_OTHER,11,Up,0.384659264041982,0.903973361513244
347,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.384763706353537,0.903973361513244
348,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Up,0.385389075866802,0.903973361513244
349,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.38556793742602,0.903973361513244
350,WP_FATTY_ACID_BETAOXIDATION,28,Down,0.38578906659514,0.903973361513244
351,WP_CANCER_PATHWAYS,304,Up,0.38600322371186,0.903973361513244
352,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Up,0.387758815780766,0.905504961851676
353,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.391989358990433,0.910303890360692
354,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.392028682710079,0.910303890360692
355,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.393372980371079,0.910852365816978
356,WP_INTEGRATED_CANCER_PATHWAY,42,Up,0.39455608667934,0.911025570928139
357,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.396773884104337,0.913580203736036
358,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,75,Up,0.398305721484921,0.914545539275433
359,WP_PLEURAL_MESOTHELIOMA,251,Up,0.403560465477327,0.920209033188981
360,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.405413555040607,0.920209033188981
361,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.405833389763133,0.920209033188981
362,WP_NEURAL_CREST_DIFFERENTIATION,38,Up,0.406281189089818,0.920209033188981
363,WP_ATM_SIGNALING,37,Up,0.40849732645472,0.920209033188981
364,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.409063556174833,0.920209033188981
365,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.409728109668086,0.920209033188981
366,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.409728109668086,0.920209033188981
367,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.411248178385441,0.921106274203902
368,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Up,0.41274607035892,0.921949102812588
369,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,29,Up,0.416640890553977,0.925982463166663
370,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,164,Up,0.418276774872422,0.925982463166663
371,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.418895716905002,0.925982463166663
372,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.419057757053526,0.925982463166663
373,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,5,Up,0.420990194354507,0.927758551633792
374,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.423197810393341,0.929071584657524
375,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.425864662566656,0.929071584657524
376,WP_SPINAL_CORD_INJURY,64,Up,0.42657832871547,0.929071584657524
377,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,48,Up,0.42690275969806,0.929071584657524
378,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.428540010154256,0.929071584657524
379,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.430605324686401,0.929071584657524
380,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.430849314319974,0.929071584657524
381,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.431354129065565,0.929071584657524
382,WP_HIPPO_SIGNALING_REGULATION,44,Up,0.431761606446546,0.929071584657524
383,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.43383995671649,0.929071584657524
384,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.436060404337082,0.929071584657524
385,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.439503898322851,0.929071584657524
386,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Up,0.441985813638382,0.929071584657524
387,WP_MONOAMINE_TRANSPORT,12,Up,0.442265592419517,0.929071584657524
388,WP_METHYLATION_PATHWAYS,5,Down,0.442757640651561,0.929071584657524
389,WP_TRYPTOPHAN_METABOLISM,17,Up,0.442805358820244,0.929071584657524
390,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.44403053267465,0.929071584657524
391,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.44572154114387,0.929071584657524
392,WP_BDNFTRKB_SIGNALING,27,Up,0.447005821826319,0.929071584657524
393,WP_ESTROGEN_SIGNALING,21,Down,0.447573767730941,0.929071584657524
394,WP_GPR40_PATHWAY,10,Down,0.4484890282007,0.929071584657524
395,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.449279832223167,0.929071584657524
396,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.451348686696952,0.929071584657524
397,WP_G13_SIGNALING,30,Up,0.453347941940798,0.929071584657524
398,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.454109111105182,0.929071584657524
399,WP_HYPERTROPHY_MODEL,13,Down,0.454668913019123,0.929071584657524
400,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.454847233789513,0.929071584657524
401,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.456170177445487,0.929071584657524
402,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,38,Down,0.456474461110037,0.929071584657524
403,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.456476035228108,0.929071584657524
404,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.456623990512944,0.929071584657524
405,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,75,Up,0.459629093230804,0.93287682626104
406,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,19,Down,0.462390320497494,0.936169565145173
407,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.466069885405601,0.93902336305952
408,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Up,0.467318005420062,0.93902336305952
409,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.467714192227639,0.93902336305952
410,WP_POSTCOVID_NEUROINFLAMMATION,11,Up,0.468496306607524,0.93902336305952
411,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.471114276213428,0.93902336305952
412,WP_KREBS_CYCLE_DISORDERS,11,Down,0.472976628460831,0.93902336305952
413,WP_IL17_SIGNALING,25,Up,0.473402045102518,0.93902336305952
414,WP_CAMKK2_PATHWAY,29,Up,0.474573533158131,0.93902336305952
415,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Up,0.474637986030321,0.93902336305952
416,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.476138850007697,0.93902336305952
417,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.476365866661581,0.93902336305952
418,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.479664132417817,0.940481504486902
419,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.479692928345991,0.940481504486902
420,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.480537994993308,0.940481504486902
421,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.482569731487131,0.940490872928689
422,WP_MIRNA_BIOGENESIS,6,Up,0.484332788858605,0.940490872928689
423,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.485269285852586,0.940490872928689
424,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.486129187538911,0.940490872928689
425,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.487772561077551,0.940490872928689
426,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.487844184485343,0.940490872928689
427,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.489765402792738,0.940490872928689
428,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Up,0.491281895616575,0.940490872928689
429,WP_OREXIN_RECEPTOR_PATHWAY,117,Up,0.495983003453306,0.940490872928689
430,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.496260840239395,0.940490872928689
431,WP_ANGIOGENESIS,13,Down,0.498897391751425,0.940490872928689
432,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Down,0.49899132757571,0.940490872928689
433,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.499998914953002,0.940490872928689
434,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.500063833910567,0.940490872928689
435,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.500344289275606,0.940490872928689
436,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Up,0.5017800050355,0.940490872928689
437,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Up,0.502485671632458,0.940490872928689
438,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Up,0.502730565081969,0.940490872928689
439,WP_NAD_METABOLISM,11,Up,0.502794469999434,0.940490872928689
440,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.504625728481949,0.940490872928689
441,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Up,0.506000297567402,0.940490872928689
442,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.506503935513915,0.940490872928689
443,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,75,Up,0.506858219838697,0.940490872928689
444,WP_ENDOCHONDRAL_OSSIFICATION,27,Down,0.511914378333461,0.943825208707627
445,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Down,0.511914378333461,0.943825208707627
446,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.514172357286157,0.943825208707627
447,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Up,0.514772927966125,0.943825208707627
448,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.514980674826664,0.943825208707627
449,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,172,Up,0.516481032015503,0.943825208707627
450,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.517651720107709,0.943825208707627
451,WP_4P163_COPY_NUMBER_VARIATION,22,Down,0.51939570343277,0.943825208707627
452,WP_ETHER_LIPID_BIOSYNTHESIS,15,Down,0.521316507217273,0.943825208707627
453,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.522740794646723,0.943825208707627
454,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.52369696513725,0.943825208707627
455,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.525528124224569,0.943825208707627
456,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.526894138138109,0.943825208707627
457,WP_SMALL_CELL_LUNG_CANCER,70,Up,0.527022705917986,0.943825208707627
458,WP_DOPAMINERGIC_NEUROGENESIS,4,Up,0.527624029838123,0.943825208707627
459,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.528434691946165,0.943825208707627
460,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.528526148827746,0.943825208707627
461,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.529322896854277,0.943825208707627
462,WP_VITAMIN_B12_METABOLISM,23,Up,0.530961838332316,0.944367640380295
463,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.531924838803013,0.944367640380295
464,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Up,0.536549157971559,0.94536044925324
465,WP_SEROTONIN_AND_ANXIETY,6,Up,0.543939914421757,0.94536044925324
466,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,42,Up,0.54881546416066,0.94536044925324
467,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.549092394119645,0.94536044925324
468,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.54993897219466,0.94536044925324
469,WP_KETOGENESIS_AND_KETOLYSIS,7,Up,0.551715420855559,0.94536044925324
470,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,35,Up,0.552740818939467,0.94536044925324
471,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.55311979778541,0.94536044925324
472,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.55313350930405,0.94536044925324
473,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.553636753052447,0.94536044925324
474,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.553675285571047,0.94536044925324
475,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.554642622920572,0.94536044925324
476,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.555908023408451,0.94536044925324
477,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.556778091086251,0.94536044925324
478,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.55758857531833,0.94536044925324
479,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.55830171488401,0.94536044925324
480,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.558918991298695,0.94536044925324
481,WP_INSULIN_SIGNALING,130,Up,0.559302964001421,0.94536044925324
482,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.562343905815544,0.94536044925324
483,WP_RETT_SYNDROME,31,Up,0.562587460391545,0.94536044925324
484,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.563770594958893,0.94536044925324
485,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Down,0.564194661774533,0.94536044925324
486,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.564815321187538,0.94536044925324
487,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.565178990283596,0.94536044925324
488,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.565732707389142,0.94536044925324
489,WP_DNA_DAMAGE_RESPONSE,63,Up,0.567465571919974,0.94536044925324
490,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Up,0.567721294416157,0.94536044925324
491,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,40,Up,0.567820899042442,0.94536044925324
492,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.567920916082536,0.94536044925324
493,WP_BASE_EXCISION_REPAIR,31,Down,0.567992231392873,0.94536044925324
494,WP_KALLMANN_SYNDROME,11,Up,0.568136328383334,0.94536044925324
495,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.570399224965293,0.947208409942366
496,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.572845014846558,0.949005194215516
497,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.575995945592227,0.949005194215516
498,WP_BARDETBIEDL_SYNDROME,65,Up,0.579565807453483,0.949005194215516
499,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,79,Up,0.582175471077848,0.949005194215516
500,WP_SPHINGOLIPID_PATHWAY,21,Down,0.582293341285069,0.949005194215516
501,WP_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.583217253538417,0.949005194215516
502,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.583217253538417,0.949005194215516
503,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,4,Up,0.583788503231878,0.949005194215516
504,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.584051811836873,0.949005194215516
505,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.584095798675437,0.949005194215516
506,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Up,0.584180812984247,0.949005194215516
507,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.592691828747807,0.959189663503212
508,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.592783879634588,0.959189663503212
509,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.600701559383478,0.967019128728148
510,WP_IL26_SIGNALING,31,Up,0.601912420843512,0.967019128728148
511,WP_SYNAPTIC_VESICLE_PATHWAY,19,Up,0.604223736005885,0.967019128728148
512,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Up,0.604416276688444,0.967019128728148
513,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.606440591047407,0.967019128728148
514,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.607098705494128,0.967019128728148
515,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.607433816151263,0.967019128728148
516,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.607727987548152,0.967019128728148
517,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Up,0.608210327922692,0.967019128728148
518,WP_ACE_INHIBITOR_PATHWAY,4,Up,0.610849859514593,0.967845963397818
519,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.612256474157724,0.967845963397818
520,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.612262653244362,0.967845963397818
521,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.614277661277892,0.967931108472446
522,WP_ALSTROM_SYNDROME,26,Up,0.614671579832867,0.967931108472446
523,WP_PDGFRBETA_PATHWAY,28,Up,0.616666859520897,0.969216364294793
524,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.618291251591319,0.969851142326485
525,WP_MACROPHAGE_MARKERS,8,Up,0.619729645821531,0.969851142326485
526,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.621134222198329,0.969851142326485
527,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.622292935449895,0.969851142326485
528,WP_NRXN1_DELETION_SYNDROME,2,Down,0.624793869956504,0.969851142326485
529,WP_TCELL_RECEPTOR_SIGNALING,72,Up,0.628927159049235,0.969851142326485
530,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.629310823233985,0.969851142326485
531,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.631631270524049,0.969851142326485
532,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.631869336008922,0.969851142326485
533,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.632288027669244,0.969851142326485
534,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.633532587739566,0.969851142326485
535,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.634101728575961,0.969851142326485
536,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.636024783079522,0.969851142326485
537,WP_SERINE_METABOLISM,8,Up,0.63980297377978,0.969851142326485
538,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.63990285630134,0.969851142326485
539,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.640109563485214,0.969851142326485
540,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.640761079120691,0.969851142326485
541,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.641684880722321,0.969851142326485
542,WP_NEPHROGENESIS,4,Up,0.642748622489105,0.969851142326485
543,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.643829895556464,0.969851142326485
544,WP_AXON_GUIDANCE,36,Down,0.64517430766843,0.969851142326485
545,WP_MALE_INFERTILITY,70,Down,0.645610560382821,0.969851142326485
546,WP_ALZHEIMERS_DISEASE,184,Up,0.64726020073985,0.969851142326485
547,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Up,0.64726020073985,0.969851142326485
548,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.648626633807327,0.969851142326485
549,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.653060781314854,0.969851142326485
550,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,135,Down,0.653180247668124,0.969851142326485
551,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Up,0.653359382642396,0.969851142326485
552,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.656419651102211,0.969851142326485
553,WP_NUCLEOTIDE_EXCISION_REPAIR,44,Down,0.656892222039861,0.969851142326485
554,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.658909003416992,0.969851142326485
555,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.660437545026726,0.969851142326485
556,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Down,0.662351068237818,0.969851142326485
557,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.662916803235894,0.969851142326485
558,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.663587732686588,0.969851142326485
559,WP_TGFBETA_RECEPTOR_SIGNALING,35,Up,0.664062756539545,0.969851142326485
560,WP_NRF2_PATHWAY,66,Down,0.667861426086654,0.969851142326485
561,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,53,Down,0.670328954123673,0.969851142326485
562,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.670629973172242,0.969851142326485
563,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.672085728681998,0.969851142326485
564,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.672494654716926,0.969851142326485
565,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Up,0.673199731619578,0.969851142326485
566,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.673501117879751,0.969851142326485
567,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.674035282019509,0.969851142326485
568,WP_WNT_SIGNALING_WP363,37,Up,0.674131090202289,0.969851142326485
569,WP_GLUTATHIONE_METABOLISM,10,Up,0.675473756531689,0.969851142326485
570,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.677283776011957,0.969851142326485
571,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Up,0.677355684162512,0.969851142326485
572,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,16,Down,0.678052511331949,0.969851142326485
573,WP_COMPLEMENT_ACTIVATION,12,Down,0.679726516692569,0.969851142326485
574,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Down,0.680804628133548,0.969851142326485
575,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.683852167841774,0.969851142326485
576,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.684253647017026,0.969851142326485
577,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.684972739914326,0.969851142326485
578,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.686676698660576,0.969851142326485
579,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Up,0.68681893513997,0.969851142326485
580,WP_ATR_SIGNALING,10,Up,0.688709990937095,0.969851142326485
581,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,75,Up,0.689520127819769,0.969851142326485
582,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Up,0.690091940917277,0.969851142326485
583,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,45,Up,0.691599950729328,0.969851142326485
584,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.691958599311682,0.969851142326485
585,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.692862598528893,0.969851142326485
586,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.694102021810298,0.969851142326485
587,WP_MICROTUBULE_CYTOSKELETON_REGULATION,36,Up,0.694378587905347,0.969851142326485
588,WP_LEPTIN_SIGNALING,70,Up,0.694560204880432,0.969851142326485
589,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.695875835787575,0.969851142326485
590,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.696654361319559,0.969851142326485
591,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.699522921185784,0.969851142326485
592,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.700210298792136,0.969851142326485
593,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.701818636062045,0.969851142326485
594,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Down,0.702554667424676,0.969851142326485
595,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.703775278898958,0.969851142326485
596,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,86,Down,0.705007683511872,0.969851142326485
597,WP_CELL_CYCLE,108,Up,0.705864717746693,0.969851142326485
598,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.707436116276629,0.969851142326485
599,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.707596659825144,0.969851142326485
600,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.70906013440519,0.969851142326485
601,WP_NPHP1_DELETION_SYNDROME,10,Down,0.710234348508232,0.969851142326485
602,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.71028027698363,0.969851142326485
603,WP_5Q35_COPY_NUMBER_VARIATION,77,Up,0.712514361212404,0.97128823369253
604,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.717668774564307,0.975914839309726
605,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.719700926440184,0.975914839309726
606,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.719983068541852,0.975914839309726
607,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.721267132287715,0.975914839309726
608,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.723215381078933,0.975914839309726
609,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.723248739399662,0.975914839309726
610,WP_ENDOTHELIN_PATHWAYS,13,Up,0.724514383182003,0.975914839309726
611,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.725406285666962,0.975914839309726
612,WP_TYPE_II_DIABETES_MELLITUS,13,Down,0.726914201981329,0.976345545798451
613,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.728872081197449,0.977378223073904
614,WP_ALLOGRAFT_REJECTION,50,Down,0.733075669052671,0.977602298415485
615,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.733430182158959,0.977602298415485
616,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.734490558410091,0.977602298415485
617,WP_G_PROTEIN_SIGNALING,63,Down,0.734716508128593,0.977602298415485
618,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.734985669611642,0.977602298415485
619,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.737958973045218,0.979971366467156
620,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.740472479743821,0.980851199711287
621,WP_MAPK_CASCADE,30,Up,0.741008023139549,0.980851199711287
622,WP_15Q11Q13_COPY_NUMBER_VARIATION,30,Up,0.744436806663415,0.983805554786699
623,WP_EGFEGFR_SIGNALING,139,Up,0.745691318471088,0.983881643311773
624,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.752075982421426,0.990188635819811
625,WP_UROTENSINIIMEDIATED_SIGNALING,50,Up,0.752880653755939,0.990188635819811
626,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.756545303903345,0.992024386855036
627,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.759172371941231,0.992024386855036
628,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.760145281114298,0.992024386855036
629,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.763070323286589,0.992024386855036
630,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.763230205238726,0.992024386855036
631,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.763422813335321,0.992024386855036
632,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.76374190274892,0.992024386855036
633,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.765040186738459,0.992024386855036
634,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.767743850266729,0.992024386855036
635,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.768266863640179,0.992024386855036
636,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Up,0.769620223599688,0.992024386855036
637,WP_15Q25_COPY_NUMBER_VARIATION,27,Up,0.769724621730302,0.992024386855036
638,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.770617740270014,0.992024386855036
639,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,34,Down,0.773971433219881,0.992024386855036
640,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,64,Up,0.774433004005971,0.992024386855036
641,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.775105182835163,0.992024386855036
642,WP_GLUCURONIDATION,7,Up,0.775308221258019,0.992024386855036
643,WP_ID_SIGNALING,12,Up,0.776592161456865,0.992024386855036
644,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Up,0.777206453935089,0.992024386855036
645,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,8,Up,0.781012837322025,0.993980845868372
646,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.78238631270639,0.993980845868372
647,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.783253157785281,0.993980845868372
648,WP_BENZENE_METABOLISM,3,Up,0.783576141268497,0.993980845868372
649,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.785827442634103,0.995300705462608
650,WP_TRANSSULFURATION_PATHWAY,8,Down,0.788171923098052,0.995352611071476
651,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.790178998880112,0.995352611071476
652,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.791023089308366,0.995352611071476
653,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.791594055346361,0.995352611071476
654,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.793276231126905,0.995352611071476
655,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,15,Up,0.795716902621739,0.995352611071476
656,WP_DNA_REPLICATION,41,Down,0.796592828490487,0.995352611071476
657,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.796640546034598,0.995352611071476
658,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Down,0.797514683367686,0.995352611071476
659,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Up,0.797977336613263,0.995352611071476
660,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.801582545024667,0.995377962852651
661,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.803650782841067,0.995377962852651
662,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,89,Up,0.803834674990893,0.995377962852651
663,WP_G1_TO_S_CELL_CYCLE_CONTROL,58,Up,0.80436701503576,0.995377962852651
664,WP_CCL18_SIGNALING,20,Up,0.807530424691837,0.995377962852651
665,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.807867422567287,0.995377962852651
666,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.81362698563909,0.995377962852651
667,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.814460512459208,0.995377962852651
668,WP_TCELL_ACTIVATION_SARSCOV2,62,Up,0.814696902495774,0.995377962852651
669,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.814861925641963,0.995377962852651
670,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Down,0.815533654870113,0.995377962852651
671,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.815774095806549,0.995377962852651
672,WP_AMINO_ACID_METABOLISM,57,Up,0.816056583026648,0.995377962852651
673,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,25,Down,0.816960568744759,0.995377962852651
674,WP_CILIARY_LANDSCAPE,185,Up,0.817314409662981,0.995377962852651
675,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.817372414751265,0.995377962852651
676,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Up,0.818668243157848,0.995481206916791
677,WP_ASPIRIN_AND_MIRNAS,8,Down,0.825599730187646,0.996835919071972
678,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.826452027039657,0.996835919071972
679,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.829022516864482,0.996835919071972
680,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,24,Down,0.829511411262122,0.996835919071972
681,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.833285056088488,0.996835919071972
682,WP_13Q1212_COPY_NUMBER_VARIATION,19,Down,0.833554460140993,0.996835919071972
683,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,10,Up,0.834811702165259,0.996835919071972
684,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.835234184091377,0.996835919071972
685,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Up,0.837923840336834,0.996835919071972
686,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Up,0.8394714462511,0.996835919071972
687,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.841171768425252,0.996835919071972
688,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Up,0.843206671102647,0.996835919071972
689,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.844009385489292,0.996835919071972
690,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.844658683836262,0.996835919071972
691,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.846234939887803,0.996835919071972
692,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.846547862508476,0.996835919071972
693,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Down,0.84833421446483,0.996835919071972
694,WP_VITAMIN_D_METABOLISM,6,Up,0.851791403724113,0.996835919071972
695,WP_VITAMIN_D_RECEPTOR_PATHWAY,83,Down,0.852092460276468,0.996835919071972
696,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.85418795745351,0.996835919071972
697,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.854780158954178,0.996835919071972
698,WP_ACUTE_VIRAL_MYOCARDITIS,63,Down,0.856845645364178,0.996835919071972
699,WP_RAS_SIGNALING,115,Down,0.857296699493847,0.996835919071972
700,WP_MEVALONATE_PATHWAY,7,Up,0.857760638452935,0.996835919071972
701,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.857826053520252,0.996835919071972
702,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,9,Up,0.858328271850456,0.996835919071972
703,WP_ENDODERM_DIFFERENTIATION,80,Down,0.859309933976381,0.996835919071972
704,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Up,0.859880506843175,0.996835919071972
705,WP_COPPER_HOMEOSTASIS,40,Up,0.861953697392478,0.996835919071972
706,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,66,Up,0.863894966334864,0.996835919071972
707,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.864689785959116,0.996835919071972
708,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.864689785959116,0.996835919071972
709,WP_DISORDERS_IN_KETOLYSIS,5,Up,0.864763838052465,0.996835919071972
710,WP_PREIMPLANTATION_EMBRYO,21,Down,0.86556893171064,0.996835919071972
711,WP_FOLATE_METABOLISM,36,Down,0.866187934315457,0.996835919071972
712,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.872599154234456,0.996835919071972
713,WP_PURINE_METABOLISM,10,Up,0.87401562306296,0.996835919071972
714,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Up,0.875591287423451,0.996835919071972
715,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.876049879947395,0.996835919071972
716,WP_TAR_SYNDROME,44,Up,0.876826670910865,0.996835919071972
717,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Up,0.87698502437691,0.996835919071972
718,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,69,Down,0.87734468067811,0.996835919071972
719,WP_FLUOROPYRIMIDINE_ACTIVITY,27,Up,0.878330225883481,0.996835919071972
720,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.881944197832781,0.996835919071972
721,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.883234724298958,0.996835919071972
722,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.884210044516211,0.996835919071972
723,WP_FOXA2_PATHWAY,9,Down,0.884994012856878,0.996835919071972
724,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.888399912180021,0.996835919071972
725,WP_IRINOTECAN_PATHWAY,5,Up,0.888739980109153,0.996835919071972
726,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.889503321463884,0.996835919071972
727,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.890677515098127,0.996835919071972
728,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,23,Down,0.891036978637604,0.996835919071972
729,WP_GASTRIC_CANCER_NETWORK_1,21,Down,0.89285004772704,0.996835919071972
730,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,14,Up,0.893099036697638,0.996835919071972
731,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.895670540000843,0.996835919071972
732,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.895756645230407,0.996835919071972
733,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.896605538331439,0.996835919071972
734,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.897841640848831,0.996835919071972
735,WP_ENERGY_METABOLISM,40,Down,0.897899269108505,0.996835919071972
736,WP_IL9_SIGNALING,14,Up,0.89964840578509,0.996835919071972
737,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Down,0.90000890011061,0.996835919071972
738,WP_HEART_DEVELOPMENT,16,Down,0.90087698267157,0.996835919071972
739,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.902311079604042,0.996835919071972
740,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,13,Up,0.90232748898157,0.996835919071972
741,WP_RETINOBLASTOMA_GENE_IN_CANCER,85,Down,0.902389080883049,0.996835919071972
742,WP_NRF2ARE_REGULATION,20,Down,0.902912276274314,0.996835919071972
743,WP_SILDENAFIL_TREATMENT,11,Down,0.90415377643211,0.996835919071972
744,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Down,0.904245847236708,0.996835919071972
745,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Up,0.904290729409816,0.996835919071972
746,WP_IL7_SIGNALING,22,Up,0.906793692007796,0.996835919071972
747,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Up,0.908179427410125,0.996835919071972
748,WP_FOXP3_IN_COVID19,9,Up,0.908467124722198,0.996835919071972
749,WP_PEPTIDE_GPCRS,12,Up,0.915050134878331,0.996835919071972
750,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Down,0.915069234494795,0.996835919071972
751,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Up,0.916207117878232,0.996835919071972
752,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.917714062594886,0.996835919071972
753,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.918488829821703,0.996835919071972
754,WP_PRIMARY_OVARIAN_INSUFFICIENCY,96,Down,0.919324818870079,0.996835919071972
755,WP_HIPPOYAP_SIGNALING,16,Up,0.92011735859824,0.996835919071972
756,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.921104901104334,0.996835919071972
757,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.921528471844491,0.996835919071972
758,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Up,0.921938712701534,0.996835919071972
759,WP_CREATINE_PATHWAY,2,Up,0.92372062786357,0.996835919071972
760,WP_AGERAGE_PATHWAY,54,Up,0.924585715656354,0.996835919071972
761,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Up,0.925033376414125,0.996835919071972
762,WP_CYTOSINE_METHYLATION,7,Up,0.926572321255141,0.996835919071972
763,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.926640303242994,0.996835919071972
764,WP_VALPROIC_ACID_PATHWAY,9,Down,0.930126114040711,0.996835919071972
765,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,42,Up,0.9301552806878,0.996835919071972
766,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.93142232371011,0.996835919071972
767,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.931735108521505,0.996835919071972
768,WP_IL18_SIGNALING,190,Up,0.932934439139122,0.996835919071972
769,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.933308237741156,0.996835919071972
770,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.937123144433516,0.996835919071972
771,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.938366429740402,0.996835919071972
772,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.939593878849795,0.996835919071972
773,WP_IRON_METABOLISM_IN_PLACENTA,10,Up,0.941879393574989,0.996835919071972
774,WP_VITAMIN_B12_DISORDERS,9,Down,0.942131868621306,0.996835919071972
775,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,89,Up,0.944997964015459,0.996835919071972
776,WP_NOTCH_SIGNALING_WP268,35,Up,0.945582282293704,0.996835919071972
777,WP_MRNA_PROCESSING,124,Up,0.945613165310492,0.996835919071972
778,WP_IL19_SIGNALING,20,Up,0.947222077484855,0.996835919071972
779,WP_DOPAMINE_METABOLISM,7,Up,0.947853008554338,0.996835919071972
780,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.952093936233709,0.996835919071972
781,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.953263863180055,0.996835919071972
782,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.954228902578434,0.996835919071972
783,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.955481572613171,0.996835919071972
784,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.955909759591403,0.996835919071972
785,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.956505735237031,0.996835919071972
786,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.957314239634963,0.996835919071972
787,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Up,0.957495242285886,0.996835919071972
788,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Down,0.958998266571936,0.996835919071972
789,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.959241305628962,0.996835919071972
790,WP_HOMOLOGOUS_RECOMBINATION,13,Down,0.960984228187237,0.996835919071972
791,WP_DNA_MISMATCH_REPAIR,23,Down,0.961522415078617,0.996835919071972
792,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,58,Up,0.961632763040378,0.996835919071972
793,WP_ADIPOGENESIS,83,Down,0.961667741878435,0.996835919071972
794,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,119,Up,0.963943465278988,0.997936433827869
795,WP_MEASLES_VIRUS_INFECTION,101,Down,0.966133287748873,0.998945361672419
796,WP_PRION_DISEASE_PATHWAY,28,Down,0.971027522757366,0.999524748453159
797,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.97181034841014,0.999524748453159
798,WP_CIRCADIAN_RHYTHM_GENES,118,Down,0.972416645012262,0.999524748453159
799,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.973449094300075,0.999524748453159
800,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.973985373674026,0.999524748453159
801,WP_SLEEP_REGULATION,10,Up,0.975140495912565,0.999524748453159
802,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.975527310325584,0.999524748453159
803,WP_CHOLESTEROL_METABOLISM,50,Up,0.978645080658012,0.999524748453159
804,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.978920154197816,0.999524748453159
805,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Up,0.979905231386326,0.999524748453159
806,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.983767846433207,0.999524748453159
807,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.985307048067501,0.999524748453159
808,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.986416571834695,0.999524748453159
809,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,124,Up,0.988432338381178,0.999524748453159
810,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.990476994075456,0.999524748453159
811,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.991347984289882,0.999524748453159
812,WP_HEME_BIOSYNTHESIS,8,Up,0.991347984289882,0.999524748453159
813,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.99158338283647,0.999524748453159
814,WP_GLYOXYLATE_METABOLISM,5,Down,0.992539234745665,0.999524748453159
815,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.994166437348555,0.999524748453159
816,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.994810030142026,0.999524748453159
817,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.996302929190557,0.999524748453159
818,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.996352759939241,0.999524748453159
819,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.996885384013382,0.999524748453159
820,WP_AUTOPHAGY,27,Up,0.998011393712979,0.999524748453159
821,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.998452220299551,0.999524748453159
822,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.999524748453159,0.999524748453159
